Calcitonin is involved in cartilage homeostasis

Is calcitonin a treatment for OA?

M. A. Karsdal, L. B. Tanko, B. J. Riis, B. C. Sondergard, K. Henriksen, Roy D Altman, P. Qvist, C. Christiansen

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Objective: Osteoarthritis (OA) is the most common form of degenerative joint diseases and a major cause of disability and impaired quality of life in the elderly. Recent observations suggest that calcitonin may act on both osteoclasts and chondrocytes. The present review was sought to summarize emerging observations from the molecular level to the preliminary clinical findings of possible chondroprotective effects of calcitonin. Method: This review summarizes peer-reviewed articles found using pre-defined search criteria and published in the PubMed database before January 2006. In addition, abstracts from the OsteoArthritis Research Society International (OARSI) conferences in the time period 2000-2005 have been included in the search. Results: Ample evidence for the effect of calcitonin on bone resorption was found. Support for direct effects of calcitonin on chondrocytes on matrix synthesis and inhibition of cartilage degradation have been published. In addition, clinical evidence for the effect of calcitonin on cartilage degradation is emerging. Conclusion: Several independent lines of evidence suggest a direct chondroprotective effect of calcitonin in addition to the well-established effect on bone resorption. Given the currently limited availability of chondroprotective agents, much expectation regards the ongoing clinical assessment of calcitonin therapy for the prevention and treatment of OA.

Original languageEnglish (US)
Pages (from-to)617-624
Number of pages8
JournalOsteoarthritis and Cartilage
Volume14
Issue number7
DOIs
StatePublished - Jul 2006
Externally publishedYes

Fingerprint

Calcitonin
Cartilage
Osteoarthritis
Homeostasis
Bone Resorption
Chondrocytes
Therapeutics
Bone
Degradation
Peer Review
Osteoclasts
PubMed
Quality of Life
Availability
Databases
Research

Keywords

  • Articular cartilage
  • Calcitonin
  • Calcitonin receptor
  • Chondrocytes
  • CTX-II
  • MMPs
  • Osteoarthritis
  • Treatment

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Karsdal, M. A., Tanko, L. B., Riis, B. J., Sondergard, B. C., Henriksen, K., Altman, R. D., ... Christiansen, C. (2006). Calcitonin is involved in cartilage homeostasis: Is calcitonin a treatment for OA? Osteoarthritis and Cartilage, 14(7), 617-624. https://doi.org/10.1016/j.joca.2006.03.014

Calcitonin is involved in cartilage homeostasis : Is calcitonin a treatment for OA? / Karsdal, M. A.; Tanko, L. B.; Riis, B. J.; Sondergard, B. C.; Henriksen, K.; Altman, Roy D; Qvist, P.; Christiansen, C.

In: Osteoarthritis and Cartilage, Vol. 14, No. 7, 07.2006, p. 617-624.

Research output: Contribution to journalArticle

Karsdal, MA, Tanko, LB, Riis, BJ, Sondergard, BC, Henriksen, K, Altman, RD, Qvist, P & Christiansen, C 2006, 'Calcitonin is involved in cartilage homeostasis: Is calcitonin a treatment for OA?', Osteoarthritis and Cartilage, vol. 14, no. 7, pp. 617-624. https://doi.org/10.1016/j.joca.2006.03.014
Karsdal MA, Tanko LB, Riis BJ, Sondergard BC, Henriksen K, Altman RD et al. Calcitonin is involved in cartilage homeostasis: Is calcitonin a treatment for OA? Osteoarthritis and Cartilage. 2006 Jul;14(7):617-624. https://doi.org/10.1016/j.joca.2006.03.014
Karsdal, M. A. ; Tanko, L. B. ; Riis, B. J. ; Sondergard, B. C. ; Henriksen, K. ; Altman, Roy D ; Qvist, P. ; Christiansen, C. / Calcitonin is involved in cartilage homeostasis : Is calcitonin a treatment for OA?. In: Osteoarthritis and Cartilage. 2006 ; Vol. 14, No. 7. pp. 617-624.
@article{01a0791e0a4e48b2ae95876c476f79a6,
title = "Calcitonin is involved in cartilage homeostasis: Is calcitonin a treatment for OA?",
abstract = "Objective: Osteoarthritis (OA) is the most common form of degenerative joint diseases and a major cause of disability and impaired quality of life in the elderly. Recent observations suggest that calcitonin may act on both osteoclasts and chondrocytes. The present review was sought to summarize emerging observations from the molecular level to the preliminary clinical findings of possible chondroprotective effects of calcitonin. Method: This review summarizes peer-reviewed articles found using pre-defined search criteria and published in the PubMed database before January 2006. In addition, abstracts from the OsteoArthritis Research Society International (OARSI) conferences in the time period 2000-2005 have been included in the search. Results: Ample evidence for the effect of calcitonin on bone resorption was found. Support for direct effects of calcitonin on chondrocytes on matrix synthesis and inhibition of cartilage degradation have been published. In addition, clinical evidence for the effect of calcitonin on cartilage degradation is emerging. Conclusion: Several independent lines of evidence suggest a direct chondroprotective effect of calcitonin in addition to the well-established effect on bone resorption. Given the currently limited availability of chondroprotective agents, much expectation regards the ongoing clinical assessment of calcitonin therapy for the prevention and treatment of OA.",
keywords = "Articular cartilage, Calcitonin, Calcitonin receptor, Chondrocytes, CTX-II, MMPs, Osteoarthritis, Treatment",
author = "Karsdal, {M. A.} and Tanko, {L. B.} and Riis, {B. J.} and Sondergard, {B. C.} and K. Henriksen and Altman, {Roy D} and P. Qvist and C. Christiansen",
year = "2006",
month = "7",
doi = "10.1016/j.joca.2006.03.014",
language = "English (US)",
volume = "14",
pages = "617--624",
journal = "Osteoarthritis and Cartilage",
issn = "1063-4584",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - Calcitonin is involved in cartilage homeostasis

T2 - Is calcitonin a treatment for OA?

AU - Karsdal, M. A.

AU - Tanko, L. B.

AU - Riis, B. J.

AU - Sondergard, B. C.

AU - Henriksen, K.

AU - Altman, Roy D

AU - Qvist, P.

AU - Christiansen, C.

PY - 2006/7

Y1 - 2006/7

N2 - Objective: Osteoarthritis (OA) is the most common form of degenerative joint diseases and a major cause of disability and impaired quality of life in the elderly. Recent observations suggest that calcitonin may act on both osteoclasts and chondrocytes. The present review was sought to summarize emerging observations from the molecular level to the preliminary clinical findings of possible chondroprotective effects of calcitonin. Method: This review summarizes peer-reviewed articles found using pre-defined search criteria and published in the PubMed database before January 2006. In addition, abstracts from the OsteoArthritis Research Society International (OARSI) conferences in the time period 2000-2005 have been included in the search. Results: Ample evidence for the effect of calcitonin on bone resorption was found. Support for direct effects of calcitonin on chondrocytes on matrix synthesis and inhibition of cartilage degradation have been published. In addition, clinical evidence for the effect of calcitonin on cartilage degradation is emerging. Conclusion: Several independent lines of evidence suggest a direct chondroprotective effect of calcitonin in addition to the well-established effect on bone resorption. Given the currently limited availability of chondroprotective agents, much expectation regards the ongoing clinical assessment of calcitonin therapy for the prevention and treatment of OA.

AB - Objective: Osteoarthritis (OA) is the most common form of degenerative joint diseases and a major cause of disability and impaired quality of life in the elderly. Recent observations suggest that calcitonin may act on both osteoclasts and chondrocytes. The present review was sought to summarize emerging observations from the molecular level to the preliminary clinical findings of possible chondroprotective effects of calcitonin. Method: This review summarizes peer-reviewed articles found using pre-defined search criteria and published in the PubMed database before January 2006. In addition, abstracts from the OsteoArthritis Research Society International (OARSI) conferences in the time period 2000-2005 have been included in the search. Results: Ample evidence for the effect of calcitonin on bone resorption was found. Support for direct effects of calcitonin on chondrocytes on matrix synthesis and inhibition of cartilage degradation have been published. In addition, clinical evidence for the effect of calcitonin on cartilage degradation is emerging. Conclusion: Several independent lines of evidence suggest a direct chondroprotective effect of calcitonin in addition to the well-established effect on bone resorption. Given the currently limited availability of chondroprotective agents, much expectation regards the ongoing clinical assessment of calcitonin therapy for the prevention and treatment of OA.

KW - Articular cartilage

KW - Calcitonin

KW - Calcitonin receptor

KW - Chondrocytes

KW - CTX-II

KW - MMPs

KW - Osteoarthritis

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=33744944563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744944563&partnerID=8YFLogxK

U2 - 10.1016/j.joca.2006.03.014

DO - 10.1016/j.joca.2006.03.014

M3 - Article

VL - 14

SP - 617

EP - 624

JO - Osteoarthritis and Cartilage

JF - Osteoarthritis and Cartilage

SN - 1063-4584

IS - 7

ER -